Wedbush analysts believe Tesla (NASDAQ:TSLA) CEO Elon Musk's unsolicited $97.4 billion bid for OpenAI's controlling nonprofit is unlikely to succeed but is intended to slow down the company's ...

Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares following the Food and Drug Administration’s approval for ...

Wedbush Securities views recent results from Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) as proof that artificial intelligence is reshaping the software industry. "The AI ...

Wedbush analyst M. Bryson now forecasts that the semiconductor producer will post earnings of $0.92 per share for the quarter, down from their previous estimate of $1.05.

Read Our Latest Research Report on MCD McDonald’s Stock Up 0.6 % MCD opened at $310.16 on Monday. McDonald’s has a 12-month low of $243.53 and a 12-month high of $317.90. The firm has a market ...

Wedbush said Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) remain the two best software plays on the AI Revolution for 2025. Analysts led by Daniel Ives said, "Palantir has been a ...

Since 1971, Travel + Leisure editors have followed one mission: to inform, inspire, and guide travelers to have deeper, more meaningful experiences. T+L's editors have traveled to countries all ...

Wedbush initiated coverage of MannKind (MNKD) with an Outperform rating and $11 price target Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

The unsolicited $97.4B bid by a group led by Elon Musk for the non-profit that controls OpenAI is not competitive, and likely aimed at slowing down the startup's capital raising process ...

Wedbush Securities views recent results from Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) as proof that artificial intelligence is reshaping the software industry. "The AI software ...